Prophylactic administration of recombinant human thrombopoietin in the secondary prevention of thrombocytopenia induced by XELOX adjuvant chemotherapy in patients with stage III colorectal cancer

ABSTRACT: Interventions: Case series:Preventive use of recombinant human thrombopoietin Primary outcome(s): platelet count Study Design: Single arm

DISEASE(S): Malignant Tumor

PROVIDER: 2700221 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR